Vertex Pharmaceuticals
Healthcare & Life Sci
Company overview
Vertex Pharmaceuticals is a biopharmaceutical company that develops medicines for serious diseases using rational drug design. Its treatments for cystic fibrosis include Trikafta. Journavx, approved in January 2025, is a non-opioid medicine for moderate to severe acute pain. Vertex also develops genetic therapies, including gene-editing treatments. It is headquartered in Boston, Massachusetts.
Vertex was founded in 1989 by Joshua Boger and Kevin J. Kinsella. By 2025 it employed 6,400 people and reported revenues of $12.0 billion, reflecting the growth of a company that turned rare-disease research into its main business.
Currently, there are no job openings at Vertex Pharmaceuticals. Over the last 30 days, 0 jobs were added and 0 were removed. Vertex Pharmaceuticals is a top-tier H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Boston, United States